Structures by: Ponnuswamy M. N.
Total: 168
2-Methoxyquinoline-3-carbaldehyde
C11H9NO2
Acta Crystallographica Section E (2010) 66, 10 o2510
a=8.8206(6)Å b=4.8446(3)Å c=21.6828(14)Å
α=90.00° β=90.612(4)° γ=90.00°
Dichloridobis(1-ethyl-2,6-dimethylpyridinium-4-olate-κ<i>O</i>)zinc(II)
[ZnCl2(C9H13NO)2]
Acta Crystallographica Section E (2010) 66, 11 m1448
a=30.365(2)Å b=8.5366(6)Å c=15.7982(12)Å
α=90.00° β=94.281(4)° γ=90.00°
3-phenyl-1<i>H</i>-pyrazole
C29H34N2S2
Acta Crystallographica Section E (2008) 64, 11 o2132-o2133
a=6.3859(5)Å b=19.1596(17)Å c=21.337(2)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-Methyl 3-(2-methyl-1-phenylsulfonyl-1<i>H</i>-indol-3-yl)but-2-enoate
C20H19NO4S
Acta Crystallographica Section E (2009) 65, 2 o431
a=8.9498(3)Å b=8.8427(2)Å c=23.2836(7)Å
α=90.00° β=97.0850(10)° γ=90.00°
Trimethyl 1-(2-methyl-1-phenylsulfonyl-1<i>H</i>-indol-3-yl)propane-1,2,3-tricarboxylate
C24H25NO8S
Acta Crystallographica Section E (2009) 65, 2 o264
a=11.0975(3)Å b=9.8255(3)Å c=22.0027(6)Å
α=90.00° β=98.605(2)° γ=90.00°
<i>tert</i>-Butyl 3-[2,2-bis(ethoxycarbonyl)vinyl]-2-methyl-1<i>H</i>-indole-1-carboxylate
C22H27NO6
Acta Crystallographica Section E (2009) 65, 4 o825
a=9.1933(3)Å b=21.8495(6)Å c=10.7676(3)Å
α=90.00° β=96.510(2)° γ=90.00°
1-Acetyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C21H23NO2
Acta Crystallographica Section E (2009) 65, 8 o1974
a=7.5622(4)Å b=10.6369(5)Å c=11.1497(7)Å
α=90.00° β=100.373(3)° γ=90.00°
1-Benzoyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C26H25NO2
Acta Crystallographica Section E (2009) 65, 8 o1975
a=10.8540(9)Å b=17.8050(17)Å c=10.8853(10)Å
α=90.00° β=94.987(3)° γ=90.00°
1N-Methyl-3,3-dicarbonitrile-4,5-dispirooxindolinpyrrolidine
C21H15N5O2
Acta Crystallographica Section E (2009) 65, 8 o1945
a=13.3173(3)Å b=9.9480(2)Å c=13.3950(3)Å
α=90.00° β=91.8270(10)° γ=90.00°
1,1'-[4-(4-Methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-diyl]diethanone
C18H21NO3
Acta Crystallographica Section E (2009) 65, 11 o2795
a=12.0781(3)Å b=8.9650(2)Å c=29.3755(8)Å
α=90.00° β=90.00° γ=90.00°
3-(4-Chlorophenyl)-1-[(<i>E</i>)-1-(4-chlorophenyl)-2-(4-methylphenylsulfanyl)ethenyl]-4-(4-methylphenylsulfanyl)-1<i>H</i>-pyrazole
C31H24Cl2N2S2
Acta Crystallographica Section E (2009) 65, 11 o2881-o2882
a=9.7515(2)Å b=10.2097(3)Å c=27.6705(6)Å
α=90.00° β=96.4020(10)° γ=90.00°
<i>tert</i>-Butyl 3-[2,2-bis(ethoxycarbonyl)vinyl]-2-bromomethyl-1<i>H</i>-indole-1-carboxylate
C22H26BrNO6
Acta Crystallographica Section E (2009) 65, 11 o2796
a=10.8682(3)Å b=11.1094(4)Å c=11.5699(6)Å
α=111.984(3)° β=105.841(2)° γ=106.926(2)°
<i>c</i>-3,<i>t</i>-3-Dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C19H21NO
Acta Crystallographica Section E (2009) 65, 11 o2794
a=6.0293(4)Å b=10.8198(6)Å c=12.1649(6)Å
α=98.559(2)° β=92.836(3)° γ=96.677(3)°
<i>c</i>-3,<i>t</i>-3-Dimethyl-4-oxo-<i>r</i>-2,<i>c</i>-6-diphenylpiperidine-1-carboxamide
C26H26N2O2
Acta Crystallographica Section E (2009) 65, 11 o2808
a=9.6648(2)Å b=10.7938(3)Å c=11.4233(3)Å
α=101.303(2)° β=90.1580(10)° γ=113.1910(10)°
Chloridobis(ethane-1,2-diamine)(4-methylaniline)cobalt(III) dichloride monohydrate
C11H25ClCoN52,2(Cl),H2O
Acta Crystallographica Section E (2009) 65, 11 m1458-m1459
a=7.3796(2)Å b=10.8367(3)Å c=12.1789(3)Å
α=75.2010(10)° β=74.671(2)° γ=78.8620(10)°
1-Chloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one
C22H24ClNO4
Acta Crystallographica Section E (2009) 65, 11 o2883
a=8.9147(8)Å b=11.9648(10)Å c=19.1365(16)Å
α=99.729(5)° β=93.665(5)° γ=90.112(6)°
<i>c</i>-3,<i>t</i>-3-Dimethyl-<i>r</i>-2,<i>c</i>-7-diphenyl-1,4-diazepan-5-one
C19H22N2O
Acta Crystallographica Section E (2009) 65, 11 o2884
a=6.7354(4)Å b=10.6867(6)Å c=11.4186(7)Å
α=82.191(3)° β=88.218(4)° γ=80.317(3)°
1-Formyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)- <i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one
C22H25NO4
Acta Crystallographica Section E (2009) 65, 11 o2818
a=11.0954(4)Å b=14.5407(3)Å c=12.7050(4)Å
α=90.00° β=110.9770(10)° γ=90.00°
1-Chloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>c</i>-3,<i>t</i>-3-dimethylpiperidin-4-one
C23H26ClNO4
Acta Crystallographica Section E (2009) 65, 11 o2793
a=12.5928(4)Å b=9.4141(3)Å c=17.9070(6)Å
α=90.00° β=90.8260(10)° γ=90.00°
<i>t</i>-3-Ethyl-<i>r</i>-2,<i>c</i>-7-bis(4-methoxyphenyl)-1,4-diazepan-5-one
C21H26N2O3
Acta Crystallographica Section E (2009) 65, 11 o2885-o2886
a=10.5190(3)Å b=13.3480(4)Å c=15.0472(4)Å
α=102.118(2)° β=93.662(2)° γ=110.287(2)°
(E)-3-(4-bromophenyl)-3-[3-(4-bromophenyl)-1H-pyrazol-1-yl]-2-propenal
C18H12Br2N2O
Acta Crystallographica Section E (2010) 66, 2 o279
a=9.2600(3)Å b=9.3782(3)Å c=37.9965(4)Å
α=90.00° β=90.00° γ=90.00°
1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one
C23H25Cl2NO4
Acta Crystallographica Section E (2010) 66, 2 o263
a=8.1251(7)Å b=9.9702(9)Å c=27.649(2)Å
α=90.00° β=92.265(5)° γ=90.00°
1-Chloroacetyl-3-isopropyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C22H24ClNO2
Acta Crystallographica Section E (2010) 66, 2 o276-o277
a=10.3415(12)Å b=9.0243(9)Å c=21.438(2)Å
α=90.00° β=90.894(3)° γ=90.00°
1-Acetyl-<i>t</i>-3-ethyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)piperidin-4-one
C23H27NO4
Acta Crystallographica Section E (2010) 66, 2 o275
a=8.6736(11)Å b=13.4578(16)Å c=17.547(2)Å
α=90.00° β=90.00° γ=90.00°
1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one
C22H23Cl2NO4
Acta Crystallographica Section E (2010) 66, 2 o262
a=19.3021(16)Å b=10.5886(9)Å c=10.3241(10)Å
α=90.00° β=91.445(5)° γ=90.00°
C37H35N3O6
C37H35N3O6
Acta Crystallographica Section E (2010) 66, 3 o646
a=9.3039(3)Å b=13.0725(3)Å c=13.8814(3)Å
α=87.5040(10)° β=74.1230(10)° γ=74.9260(10)°
(<i>E</i>)-<i>N</i>-Benzylidene-4<i>H</i>-1,2,4-triazol-4-amine
C9H8N4
Acta Crystallographica Section E (2010) 66, 3 o558
a=33.0059(11)Å b=4.06390(10)Å c=20.6535(7)Å
α=90.00° β=111.067(2)° γ=90.00°
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-{[2'-(2-ethyl-2<i>H</i>-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-oxo-2,3-dihydro-1<i>H</i>-benzimidazole-4-carboxylate
C33H34N6O6
Acta Crystallographica Section E (2010) 66, 4 o998
a=16.3770(7)Å b=8.5928(4)Å c=43.7733(19)Å
α=90.00° β=91.1500(10)° γ=90.00°
4-<i>tert</i>-Butylpyridinium picrate
C9H14N,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 4 o999
a=5.7669(12)Å b=26.798(6)Å c=11.195(3)Å
α=90.00° β=97.335(6)° γ=90.00°
4-Aminopyridinium picrate
C5H7N2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 4 o1000
a=8.5056(7)Å b=11.3338(9)Å c=14.3307(11)Å
α=90.00° β=104.162(5)° γ=90.00°
4-Hydroxy-3-(1'-methyl-2-oxo-4'-phenylspiro[indoline-3,2'-pyrrolidine]-3-ylcarbonyl)quinolin-2(1<i>H</i>)-one
C28H23N3O4
Acta Crystallographica Section E (2010) 66, 4 o952
a=9.6918(3)Å b=11.0258(3)Å c=12.9663(4)Å
α=69.1110(10)° β=72.044(2)° γ=66.4100(10)°
Cyclohexane-1-spiro-2'-imidazolidine-5'-spiro-1''-cyclohexan-4'-one
C13H22N2O
Acta Crystallographica Section E (2010) 66, 5 o1072
a=5.8270(8)Å b=10.1703(5)Å c=10.6651(4)Å
α=86.103(2)° β=81.331(3)° γ=89.720(3)°
8,9-Dimethoxy-5-phenylsulfonyl-5<i>H</i>-benzo[<i>b</i>]carbazole
C24H19NO4S
Acta Crystallographica Section E (2010) 66, 5 o1071
a=7.8606(2)Å b=9.5892(2)Å c=13.8846(4)Å
α=100.3870(10)° β=93.168(2)° γ=105.8830(10)°
Benzamide picric acid (1:1) adduct
C7H7NO,C6H3N3O7
Acta Crystallographica Section E (2010) 66, 7 o1820
a=7.8644(3)Å b=7.0664(3)Å c=25.6580(10)Å
α=90.00° β=90.978(4)° γ=90.00°
8-Methoxy-3,3,5-trimethyl-3,11-dihydropyrano[3,2-<i>a</i>]carbazole
C19H19NO2
Acta Crystallographica Section E (2010) 66, 7 o1581
a=8.290(5)Å b=8.693(5)Å c=21.326(5)Å
α=90.000(5)° β=90.742(5)° γ=90.000(5)°
2-Aminopyridinium picrate
C5H7N2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 7 o1821
a=11.2543(4)Å b=11.6588(5)Å c=12.9883(5)Å
α=114.641(4)° β=100.204(3)° γ=103.928(3)°
Dibromidobis(1-ethyl-2,6-dimethylpyridinium-4-olate-κ<i>O</i>)zinc(II)
C18H26Br2N2O2Zn
Acta Crystallographica Section E (2011) 67, 1 m103-m104
a=8.4620(10)Å b=8.5180(10)Å c=14.418(3)Å
α=93.131(6)° β=97.871(7)° γ=90.210(8)°
2-Chloro-1-(2,4,4-trimethyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-1-yl)ethanone
C14H19ClN2O
Acta Crystallographica Section E (2013) 69, 6 o874
a=10.3971(3)Å b=12.2589(3)Å c=11.0994(3)Å
α=90.00° β=93.9530(10)° γ=90.00°
({[(Carboxymethyl)sulfanyl](2-hydroxyphenyl)methyl}sulfanyl)acetic acid
C11H12O5S2
Acta Crystallographica Section E (2013) 69, 6 o893
a=7.24650(10)Å b=7.65330(10)Å c=12.0141(2)Å
α=101.094(2)° β=99.1290(10)° γ=102.390(2)°
Ethyl 3-[2-(3,4-dimethoxybenzyl)-1-phenylsulfonyl-1<i>H</i>-indol-3-yl]acrylate chloroform hemisolvate
C28H27NO6S,0.5(CHCl3)
Acta Crystallographica Section E (2011) 67, 6 o1460-o1461
a=10.2154(3)Å b=12.0504(4)Å c=12.6310(4)Å
α=70.602(2)° β=69.6130(10)° γ=77.056(2)°
2-(6-Methyl-1,2,3,4-Tetrahydro-9H-carbazol-1-ylidene)propanedinitrile
C16H13N3
Acta Crystallographica Section E (2011) 67, 12 o3270
a=7.6396(9)Å b=8.4381(8)Å c=10.8967(13)Å
α=88.395(6)° β=71.392(7)° γ=71.217(6)°
2-(6-Chloro-2,3,4,9-tetrahydro-1<i>H</i>-carbazol-1-ylidene)propanedinitrile
C15H10ClN3
Acta Crystallographica Section E (2011) 67, 12 o3268
a=7.5731(3)Å b=7.6865(3)Å c=22.2867(8)Å
α=90.00° β=97.437(2)° γ=90.00°
6-Bromo-2-[(<i>E</i>)-thiophen-2-ylmethylidene]-2,3,4,9-tetrahydro-1<i>H</i>-carbazol-1-one
C17H12BrNOS
Acta Crystallographica Section E (2011) 67, 12 o3271
a=13.8655(5)Å b=6.3081(3)Å c=17.4583(7)Å
α=90.00° β=103.666(2)° γ=90.00°
5-[1-(4-Methoxyphenyl)-2-nitrobutyl]-4-phenyl-1,2,3-selenadiazole
C19H19N3O3Se
Acta Crystallographica Section E (2012) 68, 6 o1784
a=8.3072(5)Å b=8.5468(5)Å c=13.6969(9)Å
α=81.293(3)° β=79.670(3)° γ=78.888(3)°
3-Ethyl-<i>cis</i>-2,6-diphenylpiperidine
C19H23N
Acta Crystallographica Section E (2013) 69, 9 o1441
a=5.5384(5)Å b=9.2717(9)Å c=16.0483(14)Å
α=75.508(5)° β=89.474(5)° γ=81.625(5)°
3-Isopropyl-1-{2-[(1-methyl-1<i>H</i>-tetrazol-5-yl)sulfanyl]acetyl}-2,6-diphenylpiperidin-4-one hemihydrate
C24H27N5O2S,0.5(H2O)
Acta Crystallographica Section E (2013) 69, 11 o1598
a=28.7522(9)Å b=11.1809(4)Å c=16.5584(5)Å
α=90.00° β=115.303(2)° γ=90.00°
Ethyl 2-phenyl-3-(4-phenyl-1,2,3-selenadiazol-5-yl)-3-<i>p</i>-tolylpropanoate
C26H24N2O2Se
Acta Crystallographica Section E (2012) 68, 2 o447
a=12.148(5)Å b=12.333(5)Å c=16.522(5)Å
α=90.00° β=108.768(5)° γ=90.00°
4-(5-Chlorothiophen-2-yl)-1,2,3-selenadiazole
C6H3ClN2SSe
Acta Crystallographica Section E (2013) 69, 1 o65
a=6.0412(3)Å b=19.5870(11)Å c=7.2010(4)Å
α=90.00° β=110.257(3)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-2-Chlorobenzylidene]-2-[(1,3,4-thiadiazol-2-yl)sulfanyl]acetohydrazide
C11H9ClN4OS2
Acta Crystallographica Section E (2011) 67, 10 o2612
a=7.551(5)Å b=8.743(3)Å c=11.269(5)Å
α=69.295(5)° β=87.493(4)° γ=78.892(5)°
1-Formyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C20H21NO2
Acta Crystallographica Section E (2012) 68, 3 o870
a=10.6604(6)Å b=15.7278(7)Å c=10.8066(5)Å
α=90.00° β=110.120(2)° γ=90.00°
5-(2-Nitro-1-phenylbutyl)-4-phenyl-1,2,3-selenadiazole
C18H17N3O2Se
Acta Crystallographica Section E (2012) 68, 3 o871
a=7.879(5)Å b=8.450(5)Å c=13.438(5)Å
α=80.629(5)° β=85.273(5)° γ=75.352(5)°
3-Isopropyl-2,6-bis(4-methoxyphenyl)piperidin-4-one
C22H27NO3
Acta Crystallographica Section E (2012) 68, 8 o2453
a=7.5547(3)Å b=11.8792(6)Å c=22.1103(10)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 3-(4-methoxyphenyl)-2-phenyl-3-(4-phenyl-1,2,3-selenadiazol-5-yl)propanoate
C26H24N2O3Se
Acta Crystallographica Section E (2012) 68, 8 o2347
a=11.8187(4)Å b=12.8241(5)Å c=16.1837(6)Å
α=90.00° β=105.280(2)° γ=90.00°
2-Amino-5-chloropyridinium 4-aminobenzoate
C5H6ClN2,C7H6NO2
Acta Crystallographica Section E (2012) 68, 11 o3187
a=6.9879(4)Å b=22.0074(13)Å c=8.0554(5)Å
α=90.00° β=92.7960(10)° γ=90.00°
5-[1-(4-Methylphenyl)-2-nitrobutyl]-4-phenyl-1,2,3-selenadiazole
C19H19N3O2Se
Acta Crystallographica Section E (2013) 69, 3 o430
a=8.2088(5)Å b=8.4755(5)Å c=13.7031(8)Å
α=80.669(3)° β=81.832(3)° γ=76.681(3)°
<i>cis</i>-Chlorido(ethylamine)bis(propane-1,3-diamine)cobalt(III) dichloride
C8H27ClCoN52,2(Cl)
Acta Crystallographica Section E (2013) 69, 3 m170-m171
a=7.8847(4)Å b=8.0627(4)Å c=12.6526(5)Å
α=102.780(3)° β=99.936(4)° γ=92.580(4)°
N-Dichloroacetyl-t-3,t-5-dimethyl-r-2,c-6-diphenylpiperidin-4-one
C21H21Cl2NO2
Acta Crystallographica Section E (2013) 69, 4 o609
a=8.278(2)Å b=9.714(3)Å c=11.847(3)Å
α=90.00° β=90.578(9)° γ=90.00°
<i>cis</i>-Chlorido(methylamine)bis(propane-1,3-diamine)cobalt(III) dichloride monohydrate
C7H25ClCoN52,2(Cl),H2O
Acta Crystallographica Section E (2013) 69, 4 m205-m206
a=7.4752(6)Å b=7.9065(6)Å c=14.4663(13)Å
α=76.022(6)° β=76.907(7)° γ=73.779(4)°
2-Amino-6-methylpyridinium 4-hydroxybenzoate
C6H9N2,C7H5O3
Acta Crystallographica Section E (2013) 69, 4 o610
a=11.9488(3)Å b=9.2952(3)Å c=12.4067(3)Å
α=90.00° β=117.116(2)° γ=90.00°
1-Dichloroacetyl-<i>t</i>-3-isopropyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C22H23Cl2NO2
Acta Crystallographica Section E (2013) 69, 8 o1348
a=18.4336(14)Å b=9.4516(7)Å c=11.7077(9)Å
α=90.00° β=90.00° γ=90.00°
1-(2,2-Dichloroacetyl)-3-ethyl-2,6-diphenylpiperidin-4-one
C21H21Cl2NO2
Acta Crystallographica Section E (2013) 69, 5 o800
a=17.4615(13)Å b=19.0291(15)Å c=11.9501(9)Å
α=90.00° β=91.825(5)° γ=90.00°
3,5-Dimethyl-1-{2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetyl}-2,6-diphenylpiperidin-4-one
C24H25N3O2S2
Acta Crystallographica Section E (2013) 69, 6 o845
a=9.1342(6)Å b=9.2874(6)Å c=27.0454(14)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 3-(4-chlorophenyl)-2-phenyl-3-(4-phenyl-1,2,3-selenadiazol-5-yl)propanoate
C25H21ClN2O2Se
Acta Crystallographica Section E (2013) 69, 8 o1239
a=12.1337(3)Å b=12.2267(3)Å c=16.4423(4)Å
α=90.00° β=107.7440(10)° γ=90.00°
<i>r</i>-2,<i>c</i>-6-Diphenylpiperidine
C17H19N
Acta Crystallographica Section E (2013) 69, 9 o1371
a=5.6450(9)Å b=11.2255(17)Å c=11.5281(17)Å
α=73.911(9)° β=89.898(9)° γ=81.466(9)°
3-Chloro-1-phenylsulfonyl-1H-indole-2-carbaldehyde
C15H10ClNO3S
Acta Crystallographica Section E (2006) 62, 2 o437-o439
a=8.048(2)Å b=9.568(3)Å c=9.931(3)Å
α=79.433(4)° β=82.145(4)° γ=69.839(4)°
6-Bromo-2-(3-phenylallylidene)-2,3,4,9-tetrahydro-1<i>H</i>-carbazol-1-one
C21H16BrNO
Acta Crystallographica Section E (2011) 67, 12 o3269
a=17.3682(7)Å b=14.9974(8)Å c=6.6861(3)Å
α=90.00° β=92.226(2)° γ=90.00°
C56H44ClN2O2P2RuS2
C56H44ClN2O2P2RuS2
Inorganic Chemistry Frontiers (2015) 2, 7 620
a=14.1173(5)Å b=14.4593(8)Å c=14.6783(8)Å
α=88.900(2)° β=71.657(2)° γ=85.455(2)°
C57H46As2Cl4N2O2RuS2
C57H46As2Cl4N2O2RuS2
Inorganic Chemistry Frontiers (2015) 2, 7 620
a=13.0014(5)Å b=16.8333(6)Å c=24.6941(9)Å
α=90° β=100.082(4)° γ=90°